Literature DB >> 33417657

RE: Long-Term Outcomes of Sentinel Lymph Node Biopsy for Ductal Carcinoma in Situ.

Claudia J C Meurs1, Marian B E Menke-Pluijmers2, Sabine Siesling3,4, Pieter J Westenend5.   

Abstract

Entities:  

Year:  2020        PMID： 33417657      PMCID： PMC7771425          DOI： 10.1093/jncics/pkaa079

Source DB:  PubMed          Journal:  JNCI Cancer Spectr        ISSN： 2515-5091


× No keyword cloud information.
  6 in total

1.  Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.

Authors:  Meagan E Brennan; Robin M Turner; Stefano Ciatto; M Luke Marinovich; James R French; Petra Macaskill; Nehmat Houssami
Journal:  Radiology       Date:  2011-04-14       Impact factor: 11.105

2.  International variation in management of screen-detected ductal carcinoma in situ of the breast.

Authors:  Antonio Ponti; Elsebeth Lynge; Ted James; Ondřej Májek; My von Euler-Chelpin; Ahti Anttila; Patricia Fitzpatrick; Maria Piera Mano; Masaaki Kawai; Astrid Scharpantgen; Jacques Fracheboud; Solveig Hofvind; Carmen Vidal; Nieves Ascunce; Dolores Salas; Jean-Luc Bulliard; Nereo Segnan; Karla Kerlikowske; Stephen Taplin
Journal:  Eur J Cancer       Date:  2014-08-19       Impact factor: 9.162

3.  The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.

Authors:  Ellie J Coromilas; Jason D Wright; Yongmei Huang; Sheldon Feldman; Alfred I Neugut; Ling Chen; Dawn L Hershman
Journal:  JAMA Oncol       Date:  2015-06       Impact factor: 31.777

4.  Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update.

Authors:  Gary H Lyman; Sarah Temin; Stephen B Edge; Lisa A Newman; Roderick R Turner; Donald L Weaver; Al B Benson; Linda D Bosserman; Harold J Burstein; Hiram Cody; James Hayman; Cheryl L Perkins; Donald A Podoloff; Armando E Giuliano
Journal:  J Clin Oncol       Date:  2014-03-24       Impact factor: 44.544

5.  A prediction model for underestimation of invasive breast cancer after a biopsy diagnosis of ductal carcinoma in situ: based on 2892 biopsies and 589 invasive cancers.

Authors:  Claudia J C Meurs; Joost van Rosmalen; Marian B E Menke-Pluijmers; Bert P M Ter Braak; Linda de Munck; Sabine Siesling; Pieter J Westenend
Journal:  Br J Cancer       Date:  2018-10-17       Impact factor: 7.640

6.  Long-Term Outcomes of Sentinel Lymph Node Biopsy for Ductal Carcinoma in Situ.

Authors:  Peiyin Hung; Shi-Yi Wang; Brigid K Killelea; Sarah S Mougalian; Suzanne B Evans; Tannaz Sedghi; Cary P Gross
Journal:  JNCI Cancer Spectr       Date:  2019-08-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.